| Code | 38038 | ||||||||||
| MA number | 30/0041/07-S | ||||||||||
| Product Form: | tbl mod 30x150 mg (fľ.HDPE) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | GlaxoSmithKline Trading Services Limited, Ireland | ||||||||||
| Therapeutic Class: | 30 - ANTIDEPRESSIVA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Container: | bottle HDPE | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 8(3) application - known active substance |
| MA issued: | 01.02.2007 |
| Pediatric warnings: | Yes |
| Dokument: |
DHPC buproprion 26 11 2012.pdf
|
| SPC: |
SPC_Elontril_07.2024.pdf
|
| PIL: |
PIL_Elontril_07.2024.pdf
|
| Safety feature | Yes |
| Data update: | 10.07.2024 |
